Skip Navigation
 

Formal Seminar Schedule 2001-2002

 
Date
Name of Speaker
Title
**September 7, 2001 James Mulay, MD
University of Michigan Medical Center
New Developments in Dendritic Cell-Based Tumor Vaccines
October 10, 2001 Fredric B. Kraemer, M.D.
Stanford University Medical Center
Regulation of Adipocyte Lipolysis by Hormone Sensitive Lipase
**October 12, 2001 Renee Leboeuf, PhD
University of Washington
Modeling Human Diseases in Mice: Atherosclerosis and Diabetes
October 24, 2001 John Hutton, Ph.D.
Barbara Davis Center for Diabetes, University of Colorado
Insulin Granules PTPases: Tools for the Study of
Granule Function and Involvement in Diabetes
December 5, 2001 Sheila Collins, PhD
Duke University
Uncoupling Protein-2: Transcriptional Regulation and Role in Beta Cell Insulin Secretion
December 19, 2001 George Eisenbarth, MD
Barbara Davis Center of Univ of Colorado (On sabbatical at Virginia Mason Research Center)
Insulin Autoimmunity: Predication/Promotion/ Prevention Type 1 Diabetes
January 9, 2002 Frederick Appelbaum, MD
FHCRC, Division of Clinical Research
The Evolution of Hematopoietic Cell Transplantation (RESCHEDULED FROM NOV 28)
**January 18, 2002 Philip Cryer, MD
Washington University, St. Louis
The Pathophysiology of Hypoglycemia in Diabetes
**January 25, 2002 Elizabeth R. Seaquist, M.D.
University of Minnesota
Brain Glucose Metabolism in Normal Volunteers and in Patients with Diabetes
February 13, 2002 Robert Eisenman, PhD
Fred Hutchinson Research Center
A Transcription Factor Network Regulating Cell Behavior
February 27, 2002 Christian Vaisse, MD, PhD
Univ of California San Francisco
Genetics of Human Obesity from Leptin to Melanocortins
**March 8, 2002 Ian Sweet, PhD Mechanism and Assessment of Hypoxia-Induced Death of Pancreatic Islets
March 13, 2002 Robert L Heinrikson, PhD
Pharmacia & Upjohn Corporation, Michigan
Aspartyl Proteases as Therapeutic Targets in AIDS and Alzheimer's Disease
March 27, 2002 Michael Brownlee, MD
Albert Einstein College of Medicine, NYC
Metabolite-Induced Mitochondrial Superoxide Production and Diabetic Complications
**April 5, 2002 Daniel Drucker, MD, FRCPC
University of Toronto
Glucagon-Like Peptides and the Integrated Regulation of Energy Homeostasis
April 10, 2002 Jeffrey Pessin, PhD
University of Iowa
An Adipocentric View of Insulin Signaling
April 24, 2002 Jamie Scott, MD,Ph.D.
Simon Fraser University
Peptide Ligands for Neutralizing Antibodies Against HIV-1
**May 6, 2002 Soldano Ferrone, MD, Ph.D.
Rockwell Park Cancer Institute
HLA antigen defects in melanoma. What have we learned?"
May 8, 2002 Eugene Barrett, MD, PhD
University of Virginia
The Vascular Endothelial Cell - A Target for Insulin Action
**May 21, 2002 Ralph Steinman, MD
The Rockefeller University, NYC
3rd Annual Langerhans-Virchow Lecture at the Glaser Auditorium at Swedish Time
3:30 - 4:30 PM
(Validated parking)

Dendritic Cells and the Control of Immunity and Tolerance
May 22, 2002 Ercole Cavalieri, D.Sc.
University of Nebraska Medical Center
A Unified Mechanism in the Initiation of Cancer and Other Diseases by Catechol Quinones
June 5, 2002 Vivienne Rebel, MD, PhD
Harvard University
Dana Farber Cancer Institute
Divergent roles for CBP and p300 in maintaining the hematopoietic stem cell pool

** not on a Wednesday